Role of Kupffer cells in the outgrowth of colorectal cancer liver metastases

Hepatology Research

Volumn 40, Issue 1, 2010, Pages 83-94

  Paschos, Konstantinos A ^a   Majeed, Ali W ^a   Bird, Nigel C ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Colorectal cancer; Kupffer cell; Liver defence; Liver injury; Liver macrophage; Liver metastasis

Indexed keywords

ANTIBODY; BETA2 INTEGRIN; CARCINOEMBRYONIC ANTIGEN; CD31 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; EDRECOLOMAB; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; GP75 ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 18; LECTIN; MATRIX METALLOPROTEINASE 14; MURAMYL PEPTIDE; NITROGEN DERIVATIVE; OXYGEN RADICAL; PROSTANOID; PROTEINASE; SCATTER FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANTIBODY DIRECTED ENZYME PRODRUG THERAPY; ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CELL ACTIVITY; CELL FUNCTION; CLINICAL TRIAL; COLORECTAL CANCER; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOSTASIS; DISEASE COURSE; HUMAN; KUPFFER CELL; LIVER METASTASIS; LIVER SINUSOID; NATURAL KILLER CELL; NONHUMAN; PHAGOCYTOSIS; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; REVIEW;

EID: 77954381945     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00578.x     Document Type: Review

References (98)

1. Bosetti C, Bertuccio P, Levi F, Lucchini F, Negri E, La Vecchia C. Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis. Ann Oncol 2008, 19:631-40.
2. Coleman MP, Quaresma M, Berrino F. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008, 9:730-56.
3. McMillan DC, McArdle CS. Epidemiology of colorectal liver metastases. Surg Oncol 2007, 16:3-5.
4. Bentrem DJ, Dematteo RP, Blumgart LH. Surgical therapy for metastatic disease to the liver. Annu Rev Med 2005, 56:139-56.
5. Koshariya M, Jagad RB, Kawamoto J. An update and our experience with metastatic liver disease. Hepatogastroenterology 2007, 54:2232-9.
6. McLoughlin JM, Jensen EH, Malafa M. Resection of colorectal liver metastases: current perspectives. Cancer Control 2006, 13:32-41.
7. Braet F, Nagatsuma K, Saito M, Soon L, Wisse E, Matsuura T. The hepatic sinusoidal endothelial lining and colorectal liver metastases. World J Gastroenterol 2007, 13:821-5.
8. Vekemans K, Braet F. Structural and functional aspects of the liver and liver sinusoidal cells in relation to colon carcinoma metastasis. World J Gastroenterol 2005, 11:5095-102.
9. Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int 2006, 26:1175-86.
10. Bayon LG, Izquierdo MA, Sirovich I, van Rooijen N, Beelen RH, Meijer S. Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver. Hepatology 1996, 23:1224-31.
11. Gout S, Huot J. Role of cancer microenvironment in metastasis: focus on colon cancer. Cancer Microenviron 2008, 1:69-83.
12. Fidler IJ. The pathogenesis of cancer metastasis: the " seed and soil" hypothesis revisited. Nat Rev Cancer 2003, 3:453-8.
13. Auerbach R. Patterns of tumor metastasis: organ selectivity in the spread of cancer cells. Lab Invest 1988, 58:361-4.
14. Napier SL, Healy ZR, Schnaar RL, Konstantopoulos K. Selectin ligand expression regulates the initial vascular interactions of colon carcinoma cells: the roles of CD44v and alternative sialofucosylated selectin ligands. J Biol Chem 2007, 282:3433-41.
15. Enns A, Gassmann P, Schluter K. Integrins can directly mediate metastatic tumor cell adhesion within the liver sinusoids. J Gastrointest Surg 2004, 8:1049-59. discussion 60
16. Mook OR, Van Marle J, Vreeling-Sindelarova H, Jonges R, Frederiks WM, Van Noorden CJ. Visualization of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver. Hepatology 2003, 38:295-304.
17. Ding L, Sunamura M, Kodama T. In vivo evaluation of the early events associated with liver metastasis of circulating cancer cells. Br J Cancer 2001, 85:431-8.
18. Kruskal JB, Thomas P, Kane RA, Goldberg SN. Hepatic perfusion changes in mice livers with developing colorectal cancer metastases. Radiology 2004, 231:482-90.
19. Sales JP, Wind P, Douard R, Cugnenc PH, Loric S. Blood dissemination of colonic epithelial cells during no-touch surgery for rectosigmoid cancer. Lancet 1999, 354:392.
20. Atkin G, Chopada A, Mitchell I. Colorectal cancer metastasis: in the surgeon's hands? Int Semin Surg Oncol 2005, 2:5.
21. Coffey JC, Wang JH, Smith MJ, Bouchier-Hayes D, Cotter TG, Redmond HP. Excisional surgery for cancer cure: therapy at a cost. Lancet Oncol 2003, 4:760-8.
22. Peeters CF, de Waal RM, Wobbes T, Westphal JR, Ruers TJ. Outgrowth of human liver metastases after resection of the primary colorectal tumor: a shift in the balance between apoptosis and proliferation. Int J Cancer 2006, 119:1249-53.
23. Mels AK, Statius Muller MG, van Leeuwen PA. Immune-stimulating effects of low-dose perioperative recombinant granulocyte-macrophage colony-stimulating factor in patients operated on for primary colorectal carcinoma. Br J Surg 2001, 88:539-44.
24. Schuurman B, Heuff G, Beelen RH, Meyer S. Enhanced killing capacity of human Kupffer cells after activation with human granulocyte/macrophage-colony-stimulating factor and interferon gamma. Cancer Immunol Immunother 1994, 39:179-84.
25. Naito M, Hasegawa G, Ebe Y, Yamamoto T. Differentiation and function of Kupffer cells. Med Electron Microsc 2004, 37:16-28.
26. Wisse E. An ultrastructural characterization of the endothelial cell in the rat liver sinusoid under normal and various experimental conditions, as a contribution to the distinction between endothelial and Kupffer cells. J Ultrastruct Res 1972, 38:528-62.
27. Wisse E. Kupffer cell reactions in rat liver under various conditions as observed in the electron microscope. J Ultrastruct Res 1974, 46:499-520.
28. Bouwens L, De Bleser P, Vanderkerken K, Geerts B, Wisse E. Liver cell heterogeneity: functions of non-parenchymal cells. Enzyme 1992, 46:155-68.
29. Laskin DL. Nonparenchymal cells and hepatotoxicity. Semin Liver Dis 1990, 10:293-304.
30. Alabraba EB, Curbishley SM, Lai WK, Wigmore SJ, Adams DH, Afford SC. A new approach to isolation and culture of human Kupffer cells. J Immunol Methods 2007, 326:139-44.
31. Friedman SL, Roll FJ. Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan. Anal Biochem 1987, 161:207-18.
32. Bykov I, Ylipaasto P, Eerola L, Lindros KO. Phagocytosis and LPS-stimulated production of cytokines and prostaglandin E2 is different in Kupffer cells isolated from the periportal or perivenous liver region. Scand J Gastroenterol 2003, 38:1256-61.
33. Naito M, Hasegawa G, Takahashi K. Development, differentiation, and maturation of Kupffer cells. Microsc Res Tech 1997, 39:350-64.
34. Taniguchi H, Toyoshima T, Fukao K, Nakauchi H. Presence of hematopoietic stem cells in the adult liver. Nat Med 1996, 2:198-203.
35. Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology 2006, 43:S54-62.
36. Gregory SH, Cousens LP, van Rooijen N, Dopp EA, Carlos TM, Wing EJ. Complementary adhesion molecules promote neutrophil-Kupffer cell interaction and the elimination of bacteria taken up by the liver. J Immunol 2002, 168:308-15.
37. Shi J, Gilbert GE, Kokubo Y, Ohashi T. Role of the liver in regulating numbers of circulating neutrophils. Blood 2001, 98:1226-30.
38. van Oosten M, van de Bilt E, de Vries HE, van Berkel TJ, Kuiper J. Vascular adhesion molecule-1 and intercellular adhesion molecule-1 expression on rat liver cells after lipopolysaccharide administration in vivo. Hepatology 1995, 22:1538-46.
39. Roberts RA, Ganey PE, Ju C, Kamendulis LM, Rusyn I, Klaunig JE. Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci 2007, 96:2-15.
40. Laskin DL, Weinberger B, Laskin JD. Functional heterogeneity in liver and lung macrophages. J Leukoc Biol 2001, 70:163-70.
41. Smedsrod B, De Bleser PJ, Braet F. Cell biology of liver endothelial and Kupffer cells. Gut 1994, 35:1509-16.
42. Tu Z, Bozorgzadeh A, Pierce RH, Kurtis J, Crispe IN, Orloff MS. TLR-dependent cross talk between human Kupffer cells and NK cells. J Exp Med 2008, 205:233-44.
43. Gardner CR, Wasserman AJ, Laskin DL. Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity. Cancer Res 1987, 47:6686-91.
44. Heuff G, van de Loosdrecht AA, Betjes MG, Beelen RH, Meijer S. Isolation and purification of large quantities of fresh human Kupffer cells, which are cytotoxic against colon carcinoma. Hepatology 1995, 21:740-5.
45. Nathan CF. Secretory products of macrophages. J Clin Invest 1987, 79:319-26.
46. Decker T, Lohmann-Matthes ML, Karck U, Peters T, Decker K. Comparative study of cytotoxicity, tumor necrosis factor, and prostaglandin release after stimulation of rat Kupffer cells, murine Kupffer cells, and murine inflammatory liver macrophages. J Leukoc Biol 1989, 45:139-46.
47. Gardner CR, Wasserman AJ, Laskin DL. Liver macrophage-mediated cytotoxicity toward mastocytoma cells involves phagocytosis of tumor targets. Hepatology 1991, 14:318-24.
48. Heuff G, Oldenburg HS, Boutkan H. Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells. Cancer Immunol Immunother 1993, 37:125-30.
49. Timmers M, Vekemans K, Vermijlen D. Interactions between rat colon carcinoma cells and Kupffer cells during the onset of hepatic metastasis. Int J Cancer 2004, 112:793-802.
50. Seki S, Habu Y, Kawamura T. The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses. Immunol Rev 2000, 174:35-46.
51. Su W, Kitagawa T, Ito T. Antitumor effect to IL-12 administration into the portal vein on murine liver metastasis. J Hepatobiliary Pancreat Surg 2002, 9:503-10.
52. Meterissian S, Steele GD, Thomas P. Human and murine Kupffer cell function may be altered by both intrahepatic and intrasplenic tumor deposits. Clin Exp Metastasis 1993, 11:175-82.
53. Song E, Chen J, Ouyang N, Wang M, Exton MS, Heemann U. Kupffer cells of cirrhotic rat livers sensitize colon cancer cells to Fas-mediated apoptosis. Br J Cancer 2001, 84:1265-71.
54. Gassmann P, Haier J. The tumor cell-host organ interface in the early onset of metastatic organ colonisation. Clin Exp Metastasis 2008, 25:171-81.
55. Sturm JW, Magdeburg R, Berger K. Influence of TNFA on the formation of liver metastases in a syngenic mouse model. Int J Cancer 2003, 107:11-21.
56. Zipin-Roitman A, Meshel T, Sagi-Assif O. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. Cancer Res 2007, 67:3396-405.
57. Kuespert K, Pils S, Hauck CR. CEACAMs: their role in physiology and pathophysiology. Curr Opin Cell Biol 2006, 18:565-71.
58. Thomas P, Hayashi H, Zimmer R, Forse RA. Regulation of cytokine production in carcinoembryonic antigen stimulated Kupffer cells by beta-2 adrenergic receptors: implications for hepatic metastasis. Cancer Lett 2004, 209:251-7.
59. Gangopadhyay A, Lazure DA, Kelly TM, Thomas P. Purification and analysis of an 80-kDa carcinoembryonic antigen-binding protein from Kupffer cells. Arch Biochem Biophys 1996, 328:151-7.
60. Gangopadhyay A, Lazure DA, Thomas P. Carcinoembryonic antigen induces signal transduction in Kupffer cells. Cancer Lett 1997, 118:1-6.
61. Aarons CB, Bajenova O, Andrews C. Carcinoembryonic antigen-stimulated THP-1 macrophages activate endothelial cells and increase cell-cell adhesion of colorectal cancer cells. Clin Exp Metastasis 2007, 24:201-9.
62. Kruskal JB, Azouz A, Korideck H. Hepatic colorectal cancer metastases: imaging initial steps of formation in mice. Radiology 2007, 243:703-11.
63. Jessup JM, Ishii S, Mitzoi T, Edmiston KH, Shoji Y. Carcinoembryonic antigen facilitates experimental metastasis through a mechanism that does not involve adhesion to liver cells. Clin Exp Metastasis 1999, 17:481-8.
64. Jessup JM, Samara R, Battle P, Laguinge LM. Carcinoembryonic antigen promotes tumor cell survival in liver through an IL-10-dependent pathway. Clin Exp Metastasis 2004, 21:709-17.
65. Khatib AM, Auguste P, Fallavollita L. Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis. Am J Pathol 2005, 167:749-59.
66. Auguste P, Fallavollita L, Wang N, Burnier J, Bikfalvi A, Brodt P. The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation. Am J Pathol 2007, 170:1781-92.
67. Minami S, Furui J, Kanematsu T. Role of carcinoembryonic antigen in the progression of colon cancer cells that express carbohydrate antigen. Cancer Res 2001, 61:2732-5.
68. Gangopadhyay A, Lazure DA, Thomas P. Adhesion of colorectal carcinoma cells to the endothelium is mediated by cytokines from CEA stimulated Kupffer cells. Clin Exp Metastasis 1998, 16:703-12.
69. Gallicchio M, Rosa AC, Dianzani C. Celecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29). Br J Pharmacol 2008, 153:870-8.
70. Dianzani C, Brucato L, Gallicchio M, Rosa AC, Collino M, Fantozzi R. Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression. Br J Pharmacol 2008, 153:1153-61.
71. Knittel T, Mehde M, Kobold D, Saile B, Dinter C, Ramadori G. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1. J Hepatol 1999, 30:48-60.
72. Gorden DL, Fingleton B, Crawford HC, Jansen DE, Lepage M, Matrisian LM. Resident stromal cell-derived MMP-9 promotes the growth of colorectal metastases in the liver microenvironment. Int J Cancer 2007, 121:495-500.
73. Illemann M, Bird N, Majeed A. MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases. Mol Cancer Res 2006, 4:293-302.
74. Clark A, Weymann A, Hartman E. Evidence for non-traditional activation of complement factor C3 during murine liver regeneration. Mol Immunol 2008, 45:3125-32.
75. Abshagen K, Eipel C, Kalff JC, Menger MD, Vollmar B. Kupffer cells are mandatory for adequate liver regeneration by mediating hyperperfusion via modulation of vasoactive proteins. Microcirculation 2008, 15:37-47.
76. Selzner N, Selzner M, Odermatt B, Tian Y, Van Rooijen N, Clavien PA. ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha/IL-6 in mice. Gastroenterology 2003, 124:692-700.
77. Christophi C, Harun N, Fifis T. Liver regeneration and tumor stimulation - a review of cytokine and angiogenic factors. J Gastrointest Surg 2008, 12:966-80.
78. Langenhoff BS, Krabbe PF, Ruers TJ. Efficacy of follow-up after surgical treatment of colorectal liver metastases. Eur J Surg Oncol 2009, 35:180-6.
79. Gravante G, Sconocchia G, Ong SL, Dennison AR, Lloyd DM. Immunoregulatory effects of liver ablation therapies for the treatment of primary and metastatic liver malignancies. Liver Int 2009, 29:18-24.
80. Kolios G, Valatas V, Kouroumalis E. Role of Kupffer cells in the pathogenesis of liver disease. World J Gastroenterol 2006, 12:7413-20.
81. Fukuda M, Yokoyama H, Mizukami T. Kupffer cell depletion attenuates superoxide anion release into the hepatic sinusoids after lipopolysaccharide treatment. J Gastroenterol Hepatol 2004, 19:1155-62.
82. Ramaiah SK, Jaeschke H. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol 2007, 35:757-66.
83. Salguero Palacios R, Roderfeld M, Hemmann S. Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice. Lab Invest 2008, 88:1192-203.
84. van der Bij GJ, Oosterling SJ, Meijer S, Beelen RH, van Egmond M. Therapeutic potential of Kupffer cells in prevention of liver metastases outgrowth. Immunobiology 2005, 210:259-65.
85. Waller EK. The role of sargramostim (rhGM-CSF) as immunotherapy. Oncologist 2007, 12(2):22-6. Suppl
86. Schuurman B, Koenen HJ, Beelen RH, Meyer S. Granulocyte macrophage colony stimulating factor pretreatment induces an increase of rat Kupffer cells with enhanced cytotoxicity in vitro and prevention of tumor outgrowth in vivo. Anticancer Drugs 1997, 8:269-75.
87. Suh KW, Piantadosi S, Yazdi HA, Pardoll DM, Brem H, Choti MA. Treatment of liver metastases from colon carcinoma with autologous tumor vaccine expressing granulocyte-macrophage colony-stimulating factor. J Surg Oncol 1999, 72:218-24.
88. Jain A, Slansky JE, Matey LC, Allen HE, Pardoll DM, Schulick RD. Synergistic effect of a granulocyte-macrophage colony-stimulating factor-transduced tumor vaccine and systemic interleukin-2 in the treatment of murine colorectal cancer hepatic metastases. Ann Surg Oncol 2003, 10:810-20.
89. Oosterling SJ, Mels AK, Geijtenbeek TB. Preoperative granulocyte/macrophage colony-stimulating factor (GM-CSF) increases hepatic dendritic cell numbers and clustering with lymphocytes in colorectal cancer patients. Immunobiology 2006, 211:641-9.
90. Young HA, Bream JH. IFN-gamma: recent advances in understanding regulation of expression, biological functions, and clinical applications. Curr Top Microbiol Immunol 2007, 316:97-117.
91. Rushfeldt C, Sveinbjornsson B, Seljelid R, Smedsrod B. Early events of hepatic metastasis formation in mice: role of Kupffer and NK-cells in natural and interferon-gamma-stimulated defense. J Surg Res 1999, 82:209-15.
92. Pulaski BA, Smyth MJ, Ostrand-Rosenberg S. Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma. Cancer Res 2002, 62:4406-12.
93. Karpoff HM, Jarnagin W, Delman K, Fong Y. Regional muramyl tripeptide phosphatidylethanolamine administration enhances hepatic immune function and tumor surveillance. Surgery 2000, 128:213-18.
94. Opanasopit P, Sakai M, Nishikawa M, Kawakami S, Yamashita F, Hashida M. Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers. J Control Release 2002, 80:283-94.
95. Riethmuller G, Holz E, Schlimok G. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial. J Clin Oncol 1998, 16:1788-94.
96. Otten MA, van der Bij GJ, Verbeek SJ. Experimental antibody therapy of liver metastases reveals functional redundancy between Fc gammaRI and Fc gammaRIV. J Immunol 2008, 181:6829-36.
97. Bagshawe KD. Antibody-directed enzyme prodrug therapy for cancer: its theoretical basis and application. Mol Med Today 1995, 1:424-31.
98. Kogelberg H, Tolner B, Sharma SK. Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapy. Glycobiology 2007, 17:36-45.